The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Exosome Therapy Technology Market Research Report 2025
Synopsis
Exosome therapy technology involves the use of exosomes, which are small extracellular vesicles secreted by various cell types, as therapeutic agents to treat various diseases and conditions. Exosomes are nanosized vesicles containing proteins, lipids, nucleic acids (including microRNAs), and other bioactive molecules. They play essential roles in cell-to-cell communication, and their unique properties make them promising candidates for therapeutic applications.
The global Exosome Therapy Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Exosome therapy technology has been gaining significant attention and interest from the medical and biopharmaceutical industries. The global market for exosome-based therapies has been steadily growing, driven by advancements in research and development, increasing understanding of exosome biology, and the potential of exosomes as promising therapeutic agents in various disease areas. The global market for exosome therapy technology is expected to continue its growth trajectory in the coming years. The field is likely to witness increased investments in research and development, clinical trials, and manufacturing capabilities. Advancements in exosome engineering, cargo loading, and targeting approaches are expected to enhance the therapeutic potential of exosomes for a wide range of diseases. Furthermore, as more companies and researchers enter the exosome therapeutics space, there is likely to be increased collaboration and partnerships to drive innovation and commercialization efforts. The market's future growth will depend on successful clinical trials, regulatory approvals, and the ability to address the challenges associated with standardization and large-scale manufacturing.
This report aims to provide a comprehensive presentation of the global market for Exosome Therapy Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Therapy Technology.
Report Scope
The Exosome Therapy Technology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exosome Therapy Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosome Therapy Technology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Codiak BioSciences
Capricor Therapeutics
Evox Therapeutics
ExoCarta
Aegle Therapeutics
Aruna Bio
NeuroTrauma Sciences
THERILLIA
Avalon GloboCare
CellTex Therapeutics
EVerZom
Lonza
ExoCoBio
Segment by Type
Medical Treatement
Drug Delivery Vehicle
Others
Segment by Application
Pharmaceutical Company
Hospital
Medical Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Therapy Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Exosome therapy technology involves the use of exosomes, which are small extracellular vesicles secreted by various cell types, as therapeutic agents to treat various diseases and conditions. Exosomes are nanosized vesicles containing proteins, lipids, nucleic acids (including microRNAs), and other bioactive molecules. They play essential roles in cell-to-cell communication, and their unique properties make them promising candidates for therapeutic applications.
The global Exosome Therapy Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Exosome therapy technology has been gaining significant attention and interest from the medical and biopharmaceutical industries. The global market for exosome-based therapies has been steadily growing, driven by advancements in research and development, increasing understanding of exosome biology, and the potential of exosomes as promising therapeutic agents in various disease areas. The global market for exosome therapy technology is expected to continue its growth trajectory in the coming years. The field is likely to witness increased investments in research and development, clinical trials, and manufacturing capabilities. Advancements in exosome engineering, cargo loading, and targeting approaches are expected to enhance the therapeutic potential of exosomes for a wide range of diseases. Furthermore, as more companies and researchers enter the exosome therapeutics space, there is likely to be increased collaboration and partnerships to drive innovation and commercialization efforts. The market's future growth will depend on successful clinical trials, regulatory approvals, and the ability to address the challenges associated with standardization and large-scale manufacturing.
This report aims to provide a comprehensive presentation of the global market for Exosome Therapy Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Therapy Technology.
Report Scope
The Exosome Therapy Technology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exosome Therapy Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosome Therapy Technology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Codiak BioSciences
Capricor Therapeutics
Evox Therapeutics
ExoCarta
Aegle Therapeutics
Aruna Bio
NeuroTrauma Sciences
THERILLIA
Avalon GloboCare
CellTex Therapeutics
EVerZom
Lonza
ExoCoBio
Segment by Type
Medical Treatement
Drug Delivery Vehicle
Others
Segment by Application
Pharmaceutical Company
Hospital
Medical Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Therapy Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Therapy Technology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medical Treatement
1.2.3 Drug Delivery Vehicle
1.2.4 Others
1.3 Market by Application
1.3.1 Global Exosome Therapy Technology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Hospital
1.3.4 Medical Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Therapy Technology Market Perspective (2019-2030)
2.2 Exosome Therapy Technology Growth Trends by Region
2.2.1 Global Exosome Therapy Technology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Exosome Therapy Technology Historic Market Size by Region (2019-2024)
2.2.3 Exosome Therapy Technology Forecasted Market Size by Region (2025-2030)
2.3 Exosome Therapy Technology Market Dynamics
2.3.1 Exosome Therapy Technology Industry Trends
2.3.2 Exosome Therapy Technology Market Drivers
2.3.3 Exosome Therapy Technology Market Challenges
2.3.4 Exosome Therapy Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Therapy Technology Players by Revenue
3.1.1 Global Top Exosome Therapy Technology Players by Revenue (2019-2024)
3.1.2 Global Exosome Therapy Technology Revenue Market Share by Players (2019-2024)
3.2 Global Exosome Therapy Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exosome Therapy Technology Revenue
3.4 Global Exosome Therapy Technology Market Concentration Ratio
3.4.1 Global Exosome Therapy Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapy Technology Revenue in 2023
3.5 Exosome Therapy Technology Key Players Head office and Area Served
3.6 Key Players Exosome Therapy Technology Product Solution and Service
3.7 Date of Enter into Exosome Therapy Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Therapy Technology Breakdown Data by Type
4.1 Global Exosome Therapy Technology Historic Market Size by Type (2019-2024)
4.2 Global Exosome Therapy Technology Forecasted Market Size by Type (2025-2030)
5 Exosome Therapy Technology Breakdown Data by Application
5.1 Global Exosome Therapy Technology Historic Market Size by Application (2019-2024)
5.2 Global Exosome Therapy Technology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Exosome Therapy Technology Market Size (2019-2030)
6.2 North America Exosome Therapy Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Exosome Therapy Technology Market Size by Country (2019-2024)
6.4 North America Exosome Therapy Technology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosome Therapy Technology Market Size (2019-2030)
7.2 Europe Exosome Therapy Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Exosome Therapy Technology Market Size by Country (2019-2024)
7.4 Europe Exosome Therapy Technology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Therapy Technology Market Size (2019-2030)
8.2 Asia-Pacific Exosome Therapy Technology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Exosome Therapy Technology Market Size by Region (2019-2024)
8.4 Asia-Pacific Exosome Therapy Technology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosome Therapy Technology Market Size (2019-2030)
9.2 Latin America Exosome Therapy Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Exosome Therapy Technology Market Size by Country (2019-2024)
9.4 Latin America Exosome Therapy Technology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Therapy Technology Market Size (2019-2030)
10.2 Middle East & Africa Exosome Therapy Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Exosome Therapy Technology Market Size by Country (2019-2024)
10.4 Middle East & Africa Exosome Therapy Technology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Codiak BioSciences
11.1.1 Codiak BioSciences Company Detail
11.1.2 Codiak BioSciences Business Overview
11.1.3 Codiak BioSciences Exosome Therapy Technology Introduction
11.1.4 Codiak BioSciences Revenue in Exosome Therapy Technology Business (2019-2024)
11.1.5 Codiak BioSciences Recent Development
11.2 Capricor Therapeutics
11.2.1 Capricor Therapeutics Company Detail
11.2.2 Capricor Therapeutics Business Overview
11.2.3 Capricor Therapeutics Exosome Therapy Technology Introduction
11.2.4 Capricor Therapeutics Revenue in Exosome Therapy Technology Business (2019-2024)
11.2.5 Capricor Therapeutics Recent Development
11.3 Evox Therapeutics
11.3.1 Evox Therapeutics Company Detail
11.3.2 Evox Therapeutics Business Overview
11.3.3 Evox Therapeutics Exosome Therapy Technology Introduction
11.3.4 Evox Therapeutics Revenue in Exosome Therapy Technology Business (2019-2024)
11.3.5 Evox Therapeutics Recent Development
11.4 ExoCarta
11.4.1 ExoCarta Company Detail
11.4.2 ExoCarta Business Overview
11.4.3 ExoCarta Exosome Therapy Technology Introduction
11.4.4 ExoCarta Revenue in Exosome Therapy Technology Business (2019-2024)
11.4.5 ExoCarta Recent Development
11.5 Aegle Therapeutics
11.5.1 Aegle Therapeutics Company Detail
11.5.2 Aegle Therapeutics Business Overview
11.5.3 Aegle Therapeutics Exosome Therapy Technology Introduction
11.5.4 Aegle Therapeutics Revenue in Exosome Therapy Technology Business (2019-2024)
11.5.5 Aegle Therapeutics Recent Development
11.6 Aruna Bio
11.6.1 Aruna Bio Company Detail
11.6.2 Aruna Bio Business Overview
11.6.3 Aruna Bio Exosome Therapy Technology Introduction
11.6.4 Aruna Bio Revenue in Exosome Therapy Technology Business (2019-2024)
11.6.5 Aruna Bio Recent Development
11.7 NeuroTrauma Sciences
11.7.1 NeuroTrauma Sciences Company Detail
11.7.2 NeuroTrauma Sciences Business Overview
11.7.3 NeuroTrauma Sciences Exosome Therapy Technology Introduction
11.7.4 NeuroTrauma Sciences Revenue in Exosome Therapy Technology Business (2019-2024)
11.7.5 NeuroTrauma Sciences Recent Development
11.8 THERILLIA
11.8.1 THERILLIA Company Detail
11.8.2 THERILLIA Business Overview
11.8.3 THERILLIA Exosome Therapy Technology Introduction
11.8.4 THERILLIA Revenue in Exosome Therapy Technology Business (2019-2024)
11.8.5 THERILLIA Recent Development
11.9 Avalon GloboCare
11.9.1 Avalon GloboCare Company Detail
11.9.2 Avalon GloboCare Business Overview
11.9.3 Avalon GloboCare Exosome Therapy Technology Introduction
11.9.4 Avalon GloboCare Revenue in Exosome Therapy Technology Business (2019-2024)
11.9.5 Avalon GloboCare Recent Development
11.10 CellTex Therapeutics
11.10.1 CellTex Therapeutics Company Detail
11.10.2 CellTex Therapeutics Business Overview
11.10.3 CellTex Therapeutics Exosome Therapy Technology Introduction
11.10.4 CellTex Therapeutics Revenue in Exosome Therapy Technology Business (2019-2024)
11.10.5 CellTex Therapeutics Recent Development
11.11 EVerZom
11.11.1 EVerZom Company Detail
11.11.2 EVerZom Business Overview
11.11.3 EVerZom Exosome Therapy Technology Introduction
11.11.4 EVerZom Revenue in Exosome Therapy Technology Business (2019-2024)
11.11.5 EVerZom Recent Development
11.12 Lonza
11.12.1 Lonza Company Detail
11.12.2 Lonza Business Overview
11.12.3 Lonza Exosome Therapy Technology Introduction
11.12.4 Lonza Revenue in Exosome Therapy Technology Business (2019-2024)
11.12.5 Lonza Recent Development
11.13 ExoCoBio
11.13.1 ExoCoBio Company Detail
11.13.2 ExoCoBio Business Overview
11.13.3 ExoCoBio Exosome Therapy Technology Introduction
11.13.4 ExoCoBio Revenue in Exosome Therapy Technology Business (2019-2024)
11.13.5 ExoCoBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Exosome Therapy Technology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Medical Treatement
Table 3. Key Players of Drug Delivery Vehicle
Table 4. Key Players of Others
Table 5. Global Exosome Therapy Technology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Exosome Therapy Technology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Exosome Therapy Technology Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Exosome Therapy Technology Market Share by Region (2019-2024)
Table 9. Global Exosome Therapy Technology Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Exosome Therapy Technology Market Share by Region (2025-2030)
Table 11. Exosome Therapy Technology Market Trends
Table 12. Exosome Therapy Technology Market Drivers
Table 13. Exosome Therapy Technology Market Challenges
Table 14. Exosome Therapy Technology Market Restraints
Table 15. Global Exosome Therapy Technology Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Exosome Therapy Technology Market Share by Players (2019-2024)
Table 17. Global Top Exosome Therapy Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapy Technology as of 2023)
Table 18. Ranking of Global Top Exosome Therapy Technology Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Exosome Therapy Technology Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Exosome Therapy Technology Product Solution and Service
Table 22. Date of Enter into Exosome Therapy Technology Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Exosome Therapy Technology Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Exosome Therapy Technology Revenue Market Share by Type (2019-2024)
Table 26. Global Exosome Therapy Technology Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Exosome Therapy Technology Revenue Market Share by Type (2025-2030)
Table 28. Global Exosome Therapy Technology Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Exosome Therapy Technology Revenue Market Share by Application (2019-2024)
Table 30. Global Exosome Therapy Technology Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Exosome Therapy Technology Revenue Market Share by Application (2025-2030)
Table 32. North America Exosome Therapy Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Exosome Therapy Technology Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Exosome Therapy Technology Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Exosome Therapy Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Exosome Therapy Technology Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Exosome Therapy Technology Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Exosome Therapy Technology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Exosome Therapy Technology Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Exosome Therapy Technology Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Exosome Therapy Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Exosome Therapy Technology Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Exosome Therapy Technology Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Exosome Therapy Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Exosome Therapy Technology Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Exosome Therapy Technology Market Size by Country (2025-2030) & (US$ Million)
Table 47. Codiak BioSciences Company Detail
Table 48. Codiak BioSciences Business Overview
Table 49. Codiak BioSciences Exosome Therapy Technology Product
Table 50. Codiak BioSciences Revenue in Exosome Therapy Technology Business (2019-2024) & (US$ Million)
Table 51. Codiak BioSciences Recent Development
Table 52. Capricor Therapeutics Company Detail
Table 53. Capricor Therapeutics Business Overview
Table 54. Capricor Therapeutics Exosome Therapy Technology Product
Table 55. Capricor Therapeutics Revenue in Exosome Therapy Technology Business (2019-2024) & (US$ Million)
Table 56. Capricor Therapeutics Recent Development
Table 57. Evox Therapeutics Company Detail
Table 58. Evox Therapeutics Business Overview
Table 59. Evox Therapeutics Exosome Therapy Technology Product
Table 60. Evox Therapeutics Revenue in Exosome Therapy Technology Business (2019-2024) & (US$ Million)
Table 61. Evox Therapeutics Recent Development
Table 62. ExoCarta Company Detail
Table 63. ExoCarta Business Overview
Table 64. ExoCarta Exosome Therapy Technology Product
Table 65. ExoCarta Revenue in Exosome Therapy Technology Business (2019-2024) & (US$ Million)
Table 66. ExoCarta Recent Development
Table 67. Aegle Therapeutics Company Detail
Table 68. Aegle Therapeutics Business Overview
Table 69. Aegle Therapeutics Exosome Therapy Technology Product
Table 70. Aegle Therapeutics Revenue in Exosome Therapy Technology Business (2019-2024) & (US$ Million)
Table 71. Aegle Therapeutics Recent Development
Table 72. Aruna Bio Company Detail
Table 73. Aruna Bio Business Overview
Table 74. Aruna Bio Exosome Therapy Technology Product
Table 75. Aruna Bio Revenue in Exosome Therapy Technology Business (2019-2024) & (US$ Million)
Table 76. Aruna Bio Recent Development
Table 77. NeuroTrauma Sciences Company Detail
Table 78. NeuroTrauma Sciences Business Overview
Table 79. NeuroTrauma Sciences Exosome Therapy Technology Product
Table 80. NeuroTrauma Sciences Revenue in Exosome Therapy Technology Business (2019-2024) & (US$ Million)
Table 81. NeuroTrauma Sciences Recent Development
Table 82. THERILLIA Company Detail
Table 83. THERILLIA Business Overview
Table 84. THERILLIA Exosome Therapy Technology Product
Table 85. THERILLIA Revenue in Exosome Therapy Technology Business (2019-2024) & (US$ Million)
Table 86. THERILLIA Recent Development
Table 87. Avalon GloboCare Company Detail
Table 88. Avalon GloboCare Business Overview
Table 89. Avalon GloboCare Exosome Therapy Technology Product
Table 90. Avalon GloboCare Revenue in Exosome Therapy Technology Business (2019-2024) & (US$ Million)
Table 91. Avalon GloboCare Recent Development
Table 92. CellTex Therapeutics Company Detail
Table 93. CellTex Therapeutics Business Overview
Table 94. CellTex Therapeutics Exosome Therapy Technology Product
Table 95. CellTex Therapeutics Revenue in Exosome Therapy Technology Business (2019-2024) & (US$ Million)
Table 96. CellTex Therapeutics Recent Development
Table 97. EVerZom Company Detail
Table 98. EVerZom Business Overview
Table 99. EVerZom Exosome Therapy Technology Product
Table 100. EVerZom Revenue in Exosome Therapy Technology Business (2019-2024) & (US$ Million)
Table 101. EVerZom Recent Development
Table 102. Lonza Company Detail
Table 103. Lonza Business Overview
Table 104. Lonza Exosome Therapy Technology Product
Table 105. Lonza Revenue in Exosome Therapy Technology Business (2019-2024) & (US$ Million)
Table 106. Lonza Recent Development
Table 107. ExoCoBio Company Detail
Table 108. ExoCoBio Business Overview
Table 109. ExoCoBio Exosome Therapy Technology Product
Table 110. ExoCoBio Revenue in Exosome Therapy Technology Business (2019-2024) & (US$ Million)
Table 111. ExoCoBio Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exosome Therapy Technology Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Exosome Therapy Technology Market Share by Type: 2023 VS 2030
Figure 3. Medical Treatement Features
Figure 4. Drug Delivery Vehicle Features
Figure 5. Others Features
Figure 6. Global Exosome Therapy Technology Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Exosome Therapy Technology Market Share by Application: 2023 VS 2030
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Hospital Case Studies
Figure 10. Medical Laboratory Case Studies
Figure 11. Others Case Studies
Figure 12. Exosome Therapy Technology Report Years Considered
Figure 13. Global Exosome Therapy Technology Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Exosome Therapy Technology Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Exosome Therapy Technology Market Share by Region: 2023 VS 2030
Figure 16. Global Exosome Therapy Technology Market Share by Players in 2023
Figure 17. Global Top Exosome Therapy Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapy Technology as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Exosome Therapy Technology Revenue in 2023
Figure 19. North America Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Exosome Therapy Technology Market Share by Country (2019-2030)
Figure 21. United States Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Exosome Therapy Technology Market Share by Country (2019-2030)
Figure 25. Germany Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Exosome Therapy Technology Market Share by Region (2019-2030)
Figure 33. China Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Exosome Therapy Technology Market Share by Country (2019-2030)
Figure 41. Mexico Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Exosome Therapy Technology Market Share by Country (2019-2030)
Figure 45. Turkey Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Exosome Therapy Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Codiak BioSciences Revenue Growth Rate in Exosome Therapy Technology Business (2019-2024)
Figure 48. Capricor Therapeutics Revenue Growth Rate in Exosome Therapy Technology Business (2019-2024)
Figure 49. Evox Therapeutics Revenue Growth Rate in Exosome Therapy Technology Business (2019-2024)
Figure 50. ExoCarta Revenue Growth Rate in Exosome Therapy Technology Business (2019-2024)
Figure 51. Aegle Therapeutics Revenue Growth Rate in Exosome Therapy Technology Business (2019-2024)
Figure 52. Aruna Bio Revenue Growth Rate in Exosome Therapy Technology Business (2019-2024)
Figure 53. NeuroTrauma Sciences Revenue Growth Rate in Exosome Therapy Technology Business (2019-2024)
Figure 54. THERILLIA Revenue Growth Rate in Exosome Therapy Technology Business (2019-2024)
Figure 55. Avalon GloboCare Revenue Growth Rate in Exosome Therapy Technology Business (2019-2024)
Figure 56. CellTex Therapeutics Revenue Growth Rate in Exosome Therapy Technology Business (2019-2024)
Figure 57. EVerZom Revenue Growth Rate in Exosome Therapy Technology Business (2019-2024)
Figure 58. Lonza Revenue Growth Rate in Exosome Therapy Technology Business (2019-2024)
Figure 59. ExoCoBio Revenue Growth Rate in Exosome Therapy Technology Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
